Luca Maurillo
0000-0001-7297-4988
113 papers found
Refreshing results…
The emerging role of measurable residual disease detection in AML in morphologic remission
Diagnostic performance and safety of bronchoalveolar lavage in thrombocytopenic haematological patients for invasive fungal infections diagnosis: A monocentric, retrospective experience
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes ( MDS )
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+)
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: The Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry
Treatment of Low-Blast Count AML using Hypomethylating Agents
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature
Missing publications? Search for publications with a matching author name.